Delalande Olivier, Fohlen Martine
Unité de neurochirurgie pédiatrique, Fondation Ophtalmologique A. de Rothschild, Paris, France.
Neurol Med Chir (Tokyo). 2003 Feb;43(2):61-8. doi: 10.2176/nmc.43.61.
A series of 17 patients aged from 9 months to 32 years with refractory epilepsy due to hypothalamic hamartoma were treated by total removal (one case) and disconnection (16 cases) between 1997 and 2002. The mean age at seizure onset was 16 months. Sixteen patients had gelastic seizures, 14 had partial seizures and three had generalized tonic-clonic seizures. The mean seizure frequency was 21 per day. Four patients had borderline intelligence quotient and the others were mentally retarded. Five patients presented with precocious puberty, one with acromegaly, and four suffered from obesity. Brain magnetic resonance imaging, performed at least twice in each patient, showed the hamartoma as a stable homogeneous interpeduncular mass implanted either on the mammilary tubercle or on the wall of the third ventricle with variable extension to the bottom. Ictal single photon emission computed tomography, performed in four patients, showed hyperperfusion within the hamartoma in two patients. Twenty-five operations were performed in the 17 patients. The first patient underwent total removal of the hamartoma, whereas the following 16 patients underwent disconnection through open surgery (14 procedures) and/or endoscopy (9 procedures). Eight patients became seizure-free, one patient had only brief gelastic seizures, and eight patients were dramatically improved with a mean follow up of 18.6 months (8 days to 43 months). Surgery was safe in all but two patients: the first patient had transient hemiplegia and the third cranial nerve paresis, and the other developed hemiplegia due to ischemia of the middle cerebral artery territory. The quality of life, and behavior and school performance were greatly improved in most patients. Our series illustrates the feasibility and relative safety of disconnection surgery for hypothalamic hamartomas with seizure relief in 53% of patients and dramatic improvement in the others. Surgical observations led us to propose a new anatomical classification according to the anatomical relationship between the hamartoma and the adjacent hypothalamus and third ventricle. Endoscopic disconnection seems to be a very safe way to treat hamartomas in intraventricular locations.
1997年至2002年间,对17例年龄从9个月至32岁、因下丘脑错构瘤导致难治性癫痫的患者进行了治疗,其中1例进行了全切,16例进行了离断手术。癫痫发作的平均起始年龄为16个月。16例患者有痴笑发作,14例有部分性发作,3例有全身强直阵挛发作。平均发作频率为每天21次。4例患者智商处于临界水平,其他患者均有智力发育迟缓。5例患者出现性早熟,1例出现肢端肥大症,4例患有肥胖症。每位患者至少进行了两次脑磁共振成像检查,结果显示错构瘤为稳定的均匀性脚间池肿块,附着于乳头结节或第三脑室壁,向底部的延伸程度不一。4例患者进行了发作期单光子发射计算机断层扫描,其中2例显示错构瘤内有血流灌注增加。17例患者共进行了25次手术。首例患者接受了错构瘤全切手术,而随后的16例患者通过开颅手术(14例)和/或内镜手术(9例)进行了离断手术。8例患者癫痫发作停止,1例患者仅偶有短暂的痴笑发作,8例患者有显著改善,平均随访18.6个月(8天至43个月)。除2例患者外,手术均安全:首例患者出现短暂偏瘫和动眼神经麻痹,另1例因大脑中动脉供血区缺血而出现偏瘫。大多数患者的生活质量、行为及学习表现均有显著改善。我们的系列研究表明,离断手术治疗下丘脑错构瘤具有可行性和相对安全性,53%的患者癫痫发作得到缓解,其他患者也有显著改善。手术观察使我们根据错构瘤与相邻下丘脑及第三脑室的解剖关系提出了一种新的解剖学分类。内镜离断术似乎是治疗脑室内错构瘤的一种非常安全的方法。